Epidemic of breast cancer overdiagnosis? Not so fast, according to imaging experts

A Danish study has raised eyebrows in the breast imaging world, concluding breast cancer screening is ineffective in reducing the incidence of late-stage cancer. The study was published in the Annals of Internal Medicine and was accompanied by an supporting editorial written by Otis W. Brawley, chief medical officer of the American Cancer Society.

Breast imaging societies have not taken the news lying down, with the American College of Radiology and the Society of Breast Imaging releasing a joint press release refuting the claims

"The Jørgensen paper is not based on direct patient data that shows which women had a mammogram (at what frequency) and which did not. A well-known study published in the British Medical Journal (BMJ), based on direct patient data, has shown the rate of breast cancer overdiagnosis in Denmark to be approximately 2 percent," read the statement.

In addition, Forbes contributer Elaine Schattner countered by highlighting limitations of the study, including the omission of breast ultrasound and the cross-sectional nature of the study. Read her full article by following the link below:

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.